Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (1): 44-47,52    DOI: 10.19485/j.cnki.issn2096-5087.2023.01.010
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2011—2018年余姚市恶性肿瘤发病趋势
胡碧波, 傅克本, 顾永权
余姚市疾病预防控制中心慢性病防制科,浙江 余姚 315400
Trends in incidence of malignant tumors in Yuyao City from 2011 to 2018
HU Bibo, FU Keben, GU Yongquan
Department of Non-communicable Disease Control and Prevention, Yuyao Center for Disease Control and Prevention, Yuyao, Zhejiang 315400, China
全文: PDF(871 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2011—2018年浙江省余姚市恶性肿瘤发病趋势,为制定恶性肿瘤防治策略提供依据。方法 通过宁波市数字疾控平台慢性病监测模块收集2011—2018年余姚市恶性肿瘤发病资料,计算恶性肿瘤粗发病率、中国人口标化发病率(中标率)、世界人口标化发病率(世标率)、0~74岁累积发病率、35~64岁截缩发病率和平均年度变化百分比(AAPC),分析恶性肿瘤发病趋势。结果 2011—2018年余姚市恶性肿瘤粗发病率为433.78/10万,中标率为289.37/10万,世标率为224.22/10万,0~74岁累积率为25.83%,35~64岁截缩率为83.34/10万,AAPC值分别为5.90%、3.31%、3.31%、2.84%和4.24%(均P<0.05),发病总体呈上升趋势。恶性肿瘤发病率随年龄增长呈上升趋势;其中,20~<55岁女性恶性肿瘤发病率高于同龄男性,55岁以后男性发病率高于同龄女性。发病前十位恶性肿瘤分别为肺癌、胃癌、结直肠癌、肝癌、乳腺癌、食管癌、甲状腺癌、胰腺癌、前列腺癌和宫颈癌,占全部恶性肿瘤发病的78.84%;肺癌、结直肠癌、乳腺癌、甲状腺癌、胰腺癌和前列腺癌的发病率呈逐年上升趋势,AAPC值分别为8.37%、5.36%、6.42%、24.81%、5.49%和18.78%(均P<0.05)。结论 2011—2018年余姚市恶性肿瘤发病率呈上升趋势,肺癌、甲状腺癌、女性特定恶性肿瘤、男性消化道恶性肿瘤和前列腺癌为余姚市今后的防控重点,应将防治关口前移,推进重点人群早筛早诊项目。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
胡碧波
傅克本
顾永权
关键词 恶性肿瘤发病率肺癌胃癌    
AbstractObjective To investigate the trends in incidence of malignant tumors in Yuyao City, Zhejiang Province from 2011 to 2018, so as to provide insights into formulation of the malignant tumor control strategy. Methods Data pertaining to the incidence of malignant tumor in Yuyao City from 2011 to 2018 were captured from the Chronic Disease Surveillance Module of Ningbo Municipal Digital Disease Control and Prevention Platform. The crude incidence, Chinese population-standardized incidence, global population-standardized incidence, cumulative incidence (0 to 74 years of age), and truncated age-standardized incidence (35 to 64 years of age) of malignant tumors were estimated, and the trends in incidence of malignant tumors were analyzed in Yuyao City from 2011 to 2018 using average annual percentage change (AAPC). Results The crude incidence, Chinese population-standardized incidence, global population-standardized incidence, cumulative incidence (0 to 74 years of age), and truncated age-standardized incidence (35 to 64 years of age) of malignant tumors were 433.78/105, 289.37/105, 224.22/105, 25.83% and 83.34/105 in Yuyao City from 2011 to 2018, with AAPC of 5.90%, 3.31%, 3.31%, 2.84% and 4.24%, respectively (all P<0.05), and the incidence of malignant tumors appeared an overall tendency towards a rise. The incidence of malignant tumors increased with age in Yuyao City from 2011 to 2018, and the incidence of malignant tumors was significantly higher in women than in men at ages of 20 to 54 years, while higher incidence was seen in men than in women at ages of 55 years and older. The ten most common malignant tumors included lung cancer, gastric cancer, colorectal cancer, liver cancer, breast cancer, esophageal cancer, thyroid cancer, pancreatic cancer, prostate cancer and cervical cancer, accounting for 78.84% of all malignancies, and the the incidence of lung cancer, colorectal cancer, breast cancer, thyroid cancer, pancreatic cancer and prostate cancer appeared a tendency towards a rise year by year, with AAPC of 8.37%, 5.36%, 6.42%, 24.81%, 5.49% and 18.78%, respectively (all P<0.05). Conclusions The of malignant tumors appeared a tendency towards a rise in Yuyao City from 2011 to 2018, and lung cancer, thyroid cancer, specific female cancers, male gastrointestinal and prostate cancers should be given a high priority for cancer control in Yuyao City in the future. Early screening and early diagnosis of cancers should be facilitated among high-risk populations.
Key wordsmalignant tumor    incidence    lung cancer    gastric cancer
收稿日期: 2022-08-24      修回日期: 2022-10-21      出版日期: 2023-01-10
中图分类号:  R73  
作者简介: 胡碧波,本科,主管医师,主要从事慢性病预防与控制工作
引用本文:   
胡碧波, 傅克本, 顾永权. 2011—2018年余姚市恶性肿瘤发病趋势[J]. 预防医学, 2023, 35(1): 44-47,52.
HU Bibo, FU Keben, GU Yongquan. Trends in incidence of malignant tumors in Yuyao City from 2011 to 2018. Preventive Medicine, 2023, 35(1): 44-47,52.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.01.010      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I1/44
[1] WILD C P,WEIDERPASS E,STEWART B W.World Cancer Report:cancer research for cancer prevention[M].Lyon:International Agency for Research on Cancer,2020.
[2] 李柱明,梁智恒,魏矿荣.广东省中山市2014年恶性肿瘤发病与死亡分析[J].中国肿瘤,2019,28(3):175-180.
[3] 吴春晓,顾凯,庞怡,等.2016年上海市恶性肿瘤发病和死亡情况与2002—2016年的变化趋势分析[J].中国癌症杂志,2021,31(10):879-891.
[4] 林启,周晶耀,仝振东.舟山市恶性肿瘤流行特征[J].预防医学,2022,34(3):289-293.
[5] 夏昌发,陈万青.中国恶性肿瘤负担归因于人口老龄化的比例及趋势分析[J].中华肿瘤杂志,2022,44(1):79-85.
[6] ZHENG R,ZHANG S,ZENG H,et al.Cancer incidence and mortality in China,2016[J].J Natl Cancer Center,2022,2(1):1-9.
[7] 王悠清,李辉章,龚巍巍,等.2015年浙江省肿瘤登记地区恶性肿瘤发病与死亡分析[J].中国肿瘤,2019,28(1):12-22.
[8] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[9] 林恒娜,顾秀瑛,张思维,等.全球恶性肿瘤发病年龄分析[J].中华肿瘤杂志,2018,40(7):543-549.
[10] 李辉章,杜灵彬,朱陈,等.2000—2015年浙江省肿瘤登记地区恶性肿瘤发病年龄变化特征分析[J].中华预防医学杂志,2019,53(12):1253-1258.
[11] 曹春艳,蒋卫平,王军标,等.2012—2019年海盐县居民恶性肿瘤发病趋势分析[J].预防医学,2021,33(11):1157-1160.
[12] 裘凤黔,杜娟,纪云芳,等.2012—2016年黄浦区恶性肿瘤发病和死亡分析[J].预防医学,2021,33(7):697-700.
[13] WU C C,LI M N,MENG H B,et al.Analysis of status and countermeasures of cancer incidence and mortality in China[J].Sci China Life Sci,2019,62(5):640-647.
[14] 王乐,王悠清,李辉章,等.浙江省居民恶性肿瘤防治核心知识知晓水平及影响因素分析[J].预防医学,2021,33(8):757-762.
[1] 李玉荣, 汪芬娟, 王冬飞, 林君英, 蒋园园, 高媛媛, 赵芳芳. 2015—2020年萧山区恶性肿瘤发病趋势分析[J]. 预防医学, 2023, 35(8): 687-691.
[2] 郑伟, 张世勇, 杨纶砥, 熊华利. 基于年龄-时期-队列模型的1990—2019年我国艾滋病发病率趋势分析[J]. 预防医学, 2023, 35(8): 665-668,681.
[3] 王永, 包凯芳, 王思嘉, 陈洁平, 崔军, 应焱燕, 朱银潮, 李思萱, 徐典. 2011—2022年宁波市胃癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(7): 557-562.
[4] 聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[5] 郑颖, 陈述, 钱棪梅, 唐晓翠, 李秀央. 2016—2022年金东区脑卒中发病趋势分析[J]. 预防医学, 2023, 35(7): 611-614.
[6] 王永, 应焱燕, 陈洁平, 崔军, 包凯芳, 李思萱, 朱银潮, 王思嘉, 徐典, 冯宏伟. 2002—2022年宁波市恶性肿瘤死亡趋势分析[J]. 预防医学, 2023, 35(6): 496-500,505.
[7] 初里楠, 董奕, 李竹, 张燕, 朱丹红. 2014—2021年西城区恶性肿瘤死亡及减寿分析[J]. 预防医学, 2023, 35(5): 410-414.
[8] 张瑞洁, 纪威, 韩丽媛, 张良. 2012—2021年宁波市脑卒中发病和死亡趋势分析[J]. 预防医学, 2023, 35(3): 224-228.
[9] 赵信星, 陈洪恩, 董晓, 邹泉, 梁晓峰, 吴静, 王长义. 2010—2021年南山区脑卒中发病趋势[J]. 预防医学, 2023, 35(3): 200-204.
[10] 许树红, 单杏仁, 卢巧玲, 孟海滨, 余佳琦. 2012—2021年绍兴市生殖道沙眼衣原体感染流行病学特征[J]. 预防医学, 2023, 35(2): 148-151.
[11] 项彩英, 汪德兵. 2011—2022年开化县肺癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(10): 885-889.
[12] 刘锐, 蔺茂文, 江鸿, 李舒超, 张凡, 孙春. 2008—2022年荆州市丙型病毒性肝炎发病的年龄、时期、队列趋势分析[J]. 预防医学, 2023, 35(10): 871-876.
[13] 张伟伟, 秦绪成, 李伟伟, 马昭君, 董建梅. 2014—2020年连云港市脑卒中发病趋势分析[J]. 预防医学, 2022, 34(9): 932-936,950.
[14] 王江峰, 杨诗雨, 李健强, 陈晟. 丹参酮ⅡA抑制肺癌细胞增殖研究[J]. 预防医学, 2022, 34(9): 893-897.
[15] 杨茹莱, 沈亚平, 陈迟, 周莹, 徐艳华, 舒强. 2009—2021年浙江省新生儿遗传代谢病基因型分析[J]. 预防医学, 2022, 34(8): 760-764.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed